Central Nervous System Tumors

1

Review clinical trials related to Central Nervous System Tumors. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Mirdametinib in People With Central Nervous System Tumors

The purpose of this study to find out whether mirdametinib is a safe and effective treatment for Central Nervous System/CNS tumors (glioma and neurohistiocytosis).

Participants needed: 26
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Sep 3, 2026Locations: 7
Eligibility criteria

Cohorts A and B [+28]

Is pregnant or nursing [+13]